RIO-SWITCH Consortium

No ORCID on file · 1 paper in corpus

nonrandomized-trial 2025

A Multicenter Single-Arm Study of Switching to Ferric Citrate Hydrate for Iron Deficiency Anemia in Patients Intolerant to Oral Iron: RIO-SWITCH

Advances in therapy ·doi:10.1007/s12325-025-03123-9

INTRODUCTION: Treatment interruptions due to adverse drug reactions (ADRs) are common in iron deficiency anemia (IDA). We evaluated medication completion rates and quality of life (QoL) changes in patients with IDA after starting ferric cit…